Balyasny Asset Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $59M 67M 0.88
2025-06-30 $32M 44M 0.74
2024-06-30 $5.2M 4.0M 1.29
2023-12-31 $5.1M 5.0M 1.02

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Tudor Investment Corporation
Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1